Jan-Feb 2005
A Facile and Efficient Synthetic Approach to Novel Lariat Macrocyclic Diamides
99
404 (17.5%), 300 (34%), 269 (100%), 203 (60%), 147 (99%),
121 (35%); H NMR (CDCl3): δ 1.42 (quintet, 2H, J = 5.1 Hz,
With the use of the general procedure 20a and 12c gave crude
26a which was crystallized from dioxane as colorless crystals
1
-1
NCH2CH2CH2), 1.59 (quintet, 4H, J = 5.1 Hz, NCH2CH2CH2),
2.46 (t, 4H, J = 5.1 Hz, NCH2CH2CH2), 3.14 (s, 4H, NCH2), 3.17
(s, 2H, COCH2N), 3.90-3.99 (m, 4H, OCH2), 4.99-5.06 (m, 4H,
OCH2Ar), 5.25 (m, 1H, CHOCO), 6.25-8.23 (m,16H, ArH's),
7.56 (brs, 2H, NH).
(62%), mp.144-146 °C; IR (cm ) 3385 (NH), 1750 (OCO), 1653
1
(CO amide); H NMR (CDCl3): δ 2.60 (s, 8H, NCH2), 3.14 (brs,
8H, NHCH2), 3.20 (s, 4H, COCH2N), 3.91-3.99 (m, 8H, OCH2),
4.99-5.05 (m, 8H, OCH2Ar), 5.25 (m, 2H, CHOCO) 6.24-8.23
(m, 32H, ArH's), 7.55 (brs, 4H, NH).
Anal. Calcd for C40H43N3O8 (693.795): C, 69.25; H, 6.25; N,
6.06. Found: C, 69.40; H, 6.30; N, 5.90.
nal Calcd for C74H74N6O16 (1303.429): C, 68.19; H, 5.72; N,
A
.
6.45. Found: C, 68.40; H, 5.90; N, 6.70.
13-(N-Piperidinoacetoxy)-6,12,13,20,28,29,30,31-octahydro-
14H-tetrabenzo[b,f,p,t][1,5,18,22,9,14]tetraoxadiazapentacosin-
26,33-(27H,32H)dione(22b).
1,4-Bis{6,12,13,20,28,29,30,31-octahydro-14H-tetrabenzo-
[b,f,p,t][1,5,18,22,9,14]tetraoxadiazapentacosin-26,33-
(27H,32H)dion-13-yloxycarbonylmethyl}piperazine(26b).
With the use of the general procedure 20b and 12a gave crude
22b which was crystallized from ethanol as colorless crystals
(63%), mp 181-183 °C; H NMR (CDCl3): δ 0.73 (brs, 4H,
HNCH2CH2), 1.41 (quintet, 2H, J = 5.1 Hz, NCH2CH2CH2), 1.58
(quintet, 4H, J = 5.1 Hz, NCH2CH2CH2), 2.43 (t, 4H, J = 5.1 Hz,
NCH2CH2CH2), 2.97 (m, 4H, HNCH2), 3.04 (s, 2H, COCH2N),
3.95-4.05 (m, 4H, OCH2), 5.10 (m, 4H, OCH2Ar), 5.17 (m, 1H,
CHOCO), 6.59- 8.38 (m, 16H, ArH's), 7.72 (brs, 2H, NH).
Anal. Calcd for C42H47N3O8 (721.85): C, 69.88; H, 6.56; N,
5.82. Found: C, 70.10; H, 6.70; N, 5.60.
With the use of the general procedure 20b and 12c gave crude
26b which was crystallized from ethanol as colorless crystals
1
-1
(60%), mp.122-124 °C; IR (cm ) 3387 (NH), 1750 (OCO), 1652
1
(CO, amide); H NMR (CDCl3): δ 0.72 (brs, 8H, HNCH2CH2),
2.53 (s, 8H, NCH2), 2.97 (m, 8H, HNCH2), 3.04 (s, 4H,
COCH2N), 3.94-4.05 (m, 8H, OCH2), 5.05-5.15 (m, 8H,
OCH2Ar), 5.17 (quintet, 2H, J = 2.7 Hz, CHOCO), 6.57-8.36 (m,
13
32H, ArH's), 7.71 (t, 4H, J = 3.9 Hz, NH); C NMR(CDCl3): δ
25.78, 39.79, 52.42, 58.53, 63.83, 67.2 (Aliphatic CH2's), 69.92
(Aliphatic CH), 111.84, 111.92, 121.29, 131.37, 131.71, 132.19,
132.64 (Aromatic CH's), 121.21, 122.94, 156.57, 157.21
(Aromatic C's), 164.49, 169.02 (CO).
Anal. Calcd for C78H82N6O16 (1359.536): C, 68.91; H, 6.08; N,
6.18. Found: C, 69.10; H, 6.10; N, 6.30.
13-(N-Morpholinoacetoxy)-6,12,13,20,28,29,30,31-octahydro-
14H-tetrabenzo[b,f,p,t][1,5,18,22, 9,14]tetraoxadiazapentacosin-
26,33-(27H,32H)dione (22c).
With the use of the general procedure 20b and 12b gave crude
22c which was crystallized from ethanol as colorless crystals
Reaction of Compounds 20a,b with 21a-c, 2b, 24 and 25.
(Synthesis of Compounds 23a-c, and 27-29).
-1
(60%), mp. 188-190 °C; IR (cm ) 3380 (NH), 1753 (OCO), 1650
(CO, amide); MS: m/z 723 (M+, 1.4%), 680 (5.5%), 475 (5%),
General Procedure.
1
359 (20%), 328 (18%), 246 (37%), 205 (59%), 100 (100%); H
A solution of the appropriate potassium 21a-c, 2a, 24 and 25
(10 mmol) and the chloroacetoxy compounds 20a,b (10 mmol for
synthesis of compounds 2a-c or 20 mmol for synthesis of com-
pounds 27-29) in DMF (20 ml) was heated at 80-90 °C for 5 h.
during which time KCl was precipitated. The solvent was then
removed in vacuo and the remaining material was washed with
water (50 ml) and purified to give compounds 23a-c, and 27-29.
NMR (CDCl3): δ 0.73 (s, 4H, NCH2CH2), 2.51 (t, 4H, J = 4.5
Hz, NCH2CH2O), 2.98 (m, 4H, NCH2), 3.06 (s, 2H, COCH2N),
3.71 (t, 4H, J = 4.5 Hz, NCH2CH2O), 3.90-4.08 (m, 4H, OCH2),
5.13 (m, 4H, OCH2Ar), 5.18 (quintet, 1H, J = 3 Hz,CHOCO),
13
6.59-8.38 (m, 16H, ArH's), 7.72 (brs, 2H, NH);
C
NMR(CDCl3) δ 25.85, 39.89, 53.00, 59.00, 63.92, 66.70, 67.29
(Aliphatic CH2's), 70.31 (Aliphatic CH), 111.91, 111.97, 121.37,
131.37, 131.45, 131.81, 132.31, 132.71 (Aromatic CH's), 121.32,
123.00, 156.65, 157.30 (Aromatic C's), 164.58, 169.04 (CO).
Anal. Calcd for C41H45N3O9 (723.82): C, 68.03; H, 6.27; N,
5.81. Found: C, 68.20; H, 6.40; N, 5.90.
13-(4-Formylphenoxy)acetoxy-6,12,13,20,28,29-hexahydro-
14H-tetrabenzo[b,f,n,r][1,5,16,20,9,12]tetraoxadiazatricosin-
26,31-(27H,30H)dione (23a).
With the use of the general procedure 20a and 21a gave crude
product which was purified by preparative thin layer chromatog-
raphy using CH2Cl2:MeOH (25:1) as an eluent to give 23a as col-
1,4-Bis{5,6,7,8,9,10,17,18–octahydro-16H-dibenzo[b,j]-
[1,12,5,8]dioxadiazacyclopentadecine-5,10-dion-17-yloxycar-
bonylmethyl}piperazine (14).
-1
orless crystals (50%), mp. 98-100 °C; IR (cm ) 3384 (NH), 2878
(CHO), 1763 (OCO), 1691 (CO, aldehyde), 1652 (CO, amide);
With the use of the general procedure 10 and 12c gave crude
14 which was crystallized from ethanol as colorless crystals
(60%), mp. 110-112 °C; H NMR (CDCl3): δ 2.5 (s, 8H,
MS: m/z 730 (M+, 39%), 592 (27%), 489 (33%), 414 (33%), 310
1
(72%), 166 (100%), 81 (52%); H NMR (CDCl3): δ 3.13 (brs,
1
4H, NCH2), 3.19-4.03 (m, 4H, OCH2), 4.71 (s, 2H, COCH2), 4.9-
5.0 (m, 4H, OCH2Ar), 5.32 (m, 1H, CHOCO), 6.32-8.24 (m,
22H, ArH's, NH), 9.81 (s, 1H, CHO).
Anal. Calcd for C42H38N2O10 (730.769): C, 69.03; H, 5.24; N,
3.83. Found: C, 68.90; H, 5.40; N, 4.10.
NCH2CH2N), 3.25 (s, 4H, CH2COO), 3.45-3.77 (m, 8H,
NHCH2), 4.31-4.48 (m, 8H, OCH2), 5.49 (q, 2H, J = 4.0 Hz,
13
CHOCO), 6.95-8.01 (m, 20H, ArH's, NH); C NMR (CDCl3) δ
39.29, 52.44, 59.06, 68.73 (Aliphatic CH2's), 69.47 (Aliphatic
CH), 114.29, 122.63, 131.71, 132.58 (Aromatic CH's), 132.21,
155.85 (Aromatic C's), 165.22, 68.89 (C=O).
Anal. Calcd for C46H50N6O12 (878.934): C, 62.86; H, 5.73; N,
9.56. Found: C, 62.90; H, 5.40; N, 9.40.
13-(2-Formylphenoxy)acetoxy-6,12,13,20,28,29,30,31-octahy-
dro-14H-tetrabenzo[b,f,p,t][1,5,18,22,9,14]tetraoxadiazapenta-
cosin-26,33-(27H,32H)dione (23b).
1,4-Bis{6,12,13,20,28,29-hexahydro-14H-tetrabenzo[b,f,n,r]-
[1,5,16,20,9,12]tetraoxadiazatricosin-26,31-(27H,30H)dion-13-
yloxycarbonylmethyl}piperazine (26a).
With the use of the general procedure 20b and 21b gave crude
23b which was crystallized from ethanol as colorless crystals
(55%), mp.188-190 °C; IR (cm ) 3392 (NH), 2873 (CHO), 1749
-1